John Fletcher, CEO of Fletcher Spaght, leads a strategy consulting firm focused on creating value for organizations in the healthcare, devices, cardiology, orthopedics, biopharma and healthcare IT space.
Prior to founding Fletcher Spaght, John was a Senior Manager at The Boston Consulting Group, advising a broad range of companies in healthcare and high technology industries.
John serves on the Board of Directors of Spectranetics, Axcelis and Metabolon. He is Chairman of the Corporate Collaboration Council at the Thayer School of Engineering/Tuck School of Business at Dartmouth College and serves on the Board of Advisors of Beth Israel Deaconess Medical Center and the Whitehead Institute at MIT. John received his MBA from Southern Illinois University and a BBA in Marketing from George Washington University.